Effects of combined nutritional supplementation with biotin, omega-3 polyunsaturated fatty acids and vitamin D in depression: a preclinical study
Abstract
Objectives: To evaluate the antidepressant-like effects of combined nutritional supplementation with omega-3 fatty acids, vitamin D, and biotin, alone and in combination with half-dose fluoxetine, in a Chronic Unpredictable Mild Stress (CUMS) model of depression in rats.
Methods: Thirty Sprague-Dawley rats were divided into five groups: control, disease control, fluoxetine-treated (5 mg/kg), nutrient combination (omega-3 fatty acids, vitamin D, and biotin), and nutrient combination with half-dose fluoxetine (2.5 mg/kg). Depression was induced using the CUMS model for four weeks. Behavioral assessments were performed using the sucrose preference test and elevated plus maze (EPM). Biochemical parameters including malondialdehyde (MDA), superoxide dismutase (SOD), catalase, thiol levels, and brain-derived neurotrophic factor (BDNF) were estimated. Histopathological examination of hippocampus and dentate gyrus was conducted. Data were analyzed using one-way analysis of variance followed by Tukey's post hoc test.
Results: The nutrient combination and half-dose fluoxetine with nutrient combination groups showed significant behavioral improvement vs. the disease control group, with higher sucrose preference and greater open-arm time in the EPM. Catalase activity was significantly higher in the nutrient combination group (2.50 ± 0.71 vs. 0.16 ± 0.03 pmol/min), while the half-dose fluoxetine with nutrient combination group demonstrated significantly higher SOD (2.11 ± 0.03 vs. 0.07 ±…
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.